Paclitaxel-loaded iron platinum stealth immunomicelles are potent MRI imaging agents that prevent prostate cancer growth in a PSMA-dependent manner

References

• SiegelRNaishadhamDJemalACancer statistics, 2012CA Cancer J Clin2012621102922237781
   PubMed Web of Science ®Google Scholar
• MoulJWDawsonNQuality of life associated with treatment of castration-resistant prostate cancer: a review of the literatureCancer Invest201230111222236184
   PubMed Web of Science ®Google Scholar
• BeltranHBeerTMCarducciMANew therapies for castration-resistant prostate cancer: efficacy and safetyEur Urol201160227929021592649
   PubMed Web of Science ®Google Scholar
• DayyaniFGallickGELogothetisCJCornPGNovel therapies for metastatic castrate-resistant prostate cancerJ Natl Cancer Inst2011103221665167521917607
   PubMedGoogle Scholar
• GomellaLGGelpiFKellyWKNew treatment options for castrate-resistant prostate cancer: a urology perspectiveCan J Urol20111845767577721854708
   PubMed Web of Science ®Google Scholar
• PetrylakDPCurrent clinical trials in castrate-resistant prostate cancerCurr Urol Rep201112317317921533748
   PubMedGoogle Scholar
• AbeylathSCGantaSIyerAKAmijiMCombinatorial-designed multifunctional polymeric nanosystems for tumor-targeted therapeutic deliveryAcc Chem Res201144101009101721761902
   PubMed Web of Science ®Google Scholar
• HoDSunXSunSMonodisperse magnetic nanoparticles for theranostic applicationsAcc Chem Res2011441087588221661754
   PubMed Web of Science ®Google Scholar
• KievitFMZhangMSurface engineering of iron oxide nanoparticles for targeted cancer therapyAcc Chem Res2011441085386221528865
   PubMed Web of Science ®Google Scholar
• KooHHuhMSSunICIn vivo targeted delivery of nanoparticles for theranosisAcc Chem Res201144101018102821851104
   PubMed Web of Science ®Google Scholar
• NamikiYFuchigamiTTadaNNanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoringAcc Chem Res201144101080109321786832
   PubMed Web of Science ®Google Scholar
• ShiJXiaoZKamalyNFarokhzadOCSelf-assembled targeted nanoparticles: evolution of technologies and bench to bedside translationAcc Chem Res201144101123113421692448
   PubMed Web of Science ®Google Scholar
• YooDLeeJHShinTHCheonJTheranostic magnetic nanoparticlesAcc Chem Res2011441086387421823593
   PubMed Web of Science ®Google Scholar
• PuriABlumenthalRPolymeric lipid assemblies as novel theranostic toolsAcc Chem Res201144101071107921919465
   PubMed Web of Science ®Google Scholar
• SawantRRTorchilinVPMultifunctionality of lipid-core micelles for drug delivery and tumour targetingMol Membr Biol201027723224620929339
   PubMed Web of Science ®Google Scholar
• AriasJLClaresBMoralesMEGallardoVRuizMALipid-based drug delivery systems for cancer treatmentCurr Drug Targets20111281151116521443475
   PubMed Web of Science ®Google Scholar
• Estella-Hermoso de MendozaACampaneroMAMollinedoFBlanco-PrietoMJLipid nanomedicines for anticancer drug therapyJ Biomed Nanotechnol20095432334320055079
   PubMed Web of Science ®Google Scholar
• FlorenceATJaniPUNovel oral drug formulations. Their potential in modulating adverse effectsDrug Saf19941032332668043223
   PubMed Web of Science ®Google Scholar
• PengXHQianXMaoHTargeted magnetic iron oxide nanoparticles for tumor imaging and therapyInt J Nanomedicine20083331132118990940
   PubMed Web of Science ®Google Scholar
• AkhterSAhmadZSinghACancer targeted metallic nanoparticle: targeting overview, recent advancement and toxicity concernCurr Pharm Des201117181834185021568874
   PubMed Web of Science ®Google Scholar
• HirsjarviSPassiraniCBenoitJPPassive and active tumour targeting with nanocarriersCurr Drug Discov Technol20118318819621513482
   PubMedGoogle Scholar
• ZhangCLiuTGaoJSuYShiCRecent development and application of magnetic nanoparticles for cell labeling and imagingMini Rev Med Chem201010319320220408802
   PubMed Web of Science ®Google Scholar
• LinMMKim doKEl HajAJDobsonJDevelopment of superparamagnetic iron oxide nanoparticles (SPIONS) for translation to clinical applicationsIEEE Trans Nanobioscience20087429830519203873
   PubMed Web of Science ®Google Scholar
• ShubayevVIPisanicTR2ndJinSMagnetic nanoparticles for theragnosticsAdv Drug Deliv Rev200961646747719389434
   PubMed Web of Science ®Google Scholar
• MailanderVLandfesterKInteraction of nanoparticles with cellsBiomacromolecules20091092379240019637907
   PubMed Web of Science ®Google Scholar
• GandhiSNBrownMAWongJGAguirreDASirlinCBMR contrast agents for liver imaging: what, when, howRadiographics20062661621163617102040
   PubMed Web of Science ®Google Scholar
• TsukadaHApplication of pre-clinical PET imaging for drug developmentNihon Shinkei Seishin Yakurigaku Zasshi2011315–6231237 Japanese.22256612
   PubMedGoogle Scholar
• TaylorRMHuberDLMonsonTCEschVSillerudLOStructural and magnetic characterization of superparamagnetic iron platinum nanoparticle contrast agents for magnetic resonance imagingJ Vac Sci Technol B2012302
   Web of Science ®Google Scholar
• TaylorRMHuberDLMonsonTCAliAMBisoffiMSillerudLOMultifunctional iron platinum stealth immunomicelles: targeted detection of human prostate cancer cells using both fluorescence and magnetic resonance imagingJ Nanopart Res201113104717472922121333
   PubMed Web of Science ®Google Scholar
• RasbandWSImageJ. US National Institutes of Health, Bethesda, Maryland, USA, 1997–2009 Available from: http//rsbinfo/nih/gov/ij/. Accessed July 4, 2012.
   Google Scholar
• GossuinYGillisPHocqAVuongQLRochAMagnetic resonance relaxation properties of superparamagnetic particlesWiley Interdiscip Rev Nanomed Nanobiotechnol20091329931020049798
   PubMed Web of Science ®Google Scholar
• HuangJZhongXWangLYangLMaoHImproving the magnetic resonance imaging contrast and detection methods with engineered magnetic nanoparticlesTheranostics2012218610222272222
   PubMed Web of Science ®Google Scholar
• LeeJHHuhYMJunYWArtificially engineered magnetic nanoparticles for ultra-sensitive molecular imagingNat Med2007131959917187073
   PubMed Web of Science ®Google Scholar
• CarrollMRHuffstetlerPPMilesWCThe effect of polymer coatings on proton transverse relaxivities of aqueous suspensions of magnetic nanoparticlesNanotechnology2011223232570221772073
   PubMed Web of Science ®Google Scholar
• DieziTABaeYKwonGSEnhanced stability of PEG-block-poly(N-hexyl stearate l-aspartamide) micelles in the presence of serum proteinsMol Pharm2010741355136020575526
   PubMed Web of Science ®Google Scholar
• KastantinMMissirlisDBlackMAnanthanarayananBPetersDTirrellMThermodynamic and kinetic stability of DSPE-PEG(2000) micelles in the presence of bovine serum albuminJ Phys Chem B201011439126321264020828210
   PubMed Web of Science ®Google Scholar
• LuJOwenSCShoichetMSStability of self-assembled polymeric micelles in serumMacromolecules201144156002600821818161
   PubMed Web of Science ®Google Scholar
• TaylorRMSevernsVBrownDCBisoffiMSillerudLOProstate cancer targeting motifs: Expression of alpha(nu) beta(3), neurotensin receptor 1, prostate specific membrane antigen, and prostate stem cell antigen in human prostate cancer cell lines and xenograftsProstate201272552353221748756
   PubMed Web of Science ®Google Scholar
• CouraudSPlanusCRioufolCMornexFPlatinum salts hypersensitivityRev Pneumol Clin20086412026 French.18603175
   PubMed Web of Science ®Google Scholar
• CristaudoASeraFSeverinoVDe RoccoMDi LellaEPicardoMOccupational hypersensitivity to metal salts, including platinum, in the secondary industryAllergy200560215916415647035
   PubMed Web of Science ®Google Scholar
• TouraineFSainte LaudyJBoumedieneAInvestigation of allergic reactions to platinum saltsRev Mal Respir2006235 Pt 1458462 French.17314746
   PubMed Web of Science ®Google Scholar
• ZhaoJKimJEReedELiQQMolecular mechanism of antitumor activity of taxanes in lung cancerInt J Oncol200527124725615942666
   PubMed Web of Science ®Google Scholar
• NieSUnderstanding and overcoming major barriers in cancer nanomedicineNanomedicine (Lond)20105452352820528447
   PubMed Web of Science ®Google Scholar
• AkhtarNHPailOSaranATyrellLTagawaSTProstate-specific membrane antigen-based therapeuticsAdv Urol2012201297382021811498
   PubMedGoogle Scholar
• BanderNHTrabulsiEJKostakogluLTargeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigenJ Urol200317051717172114532761
   PubMed Web of Science ®Google Scholar
• BayesMRabassedaXProusJRGateways to clinical trialsMethods Find Exp Clin Pharmacol200729642743717922073
   PubMedGoogle Scholar
• NanusDMMilowskyMIKostakogluLClinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigenJ Urol.20031706 Pt 2S84S8814610416
   PubMed Web of Science ®Google Scholar
• RiceSLRoneyCADaumarPLewisJSThe next generation of positron emission tomography radiopharmaceuticals in oncologySemin Nucl Med201141426528221624561
   PubMed Web of Science ®Google Scholar
• TagawaSTBeltranHVallabhajosulaSAnti-prostate-specific membrane antigen-based radioimmunotherapy for prostate cancerCancer20101164 Suppl1075108320127956
   PubMed Web of Science ®Google Scholar
• ChangSSO’KeefeDSBacichDJReuterVEHestonWDGaudinPBProstate-specific membrane antigen is produced in tumor-associated neovasculatureClin Cancer Res19995102674268110537328
   PubMed Web of Science ®Google Scholar